Leakage Rate of Ileo-COlic Sutured Anastomosis After Right Hemicolectomy

NCT ID: NCT07132970

Last Updated: 2026-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

249 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-26

Study Completion Date

2028-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of the study is to show that the ileo-colic anastomosis leakage rate until the first 30 days after surgery using MonoPlus® suture material for anastomosis construction after right hemicolectomy is not inferior to the anastomosis leakage rate published in the literature for totally handsewn or stapled-handsewn ileo-colic anastomosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will include patients with right colon cancer, treated with elective colectomy and with local curative intention, in whom primary anastomosis with no protective stoma will be performed. Right colectomy is defined as a resection of terminal 10 cm of ileum, the cecum, the ascending right colon, and right third or half of the transverse colon followed by ileo-colostomy.The anastomosis leakage rate after right-sided hemicolectomy is the most important complication, because it leads to further morbidity of the affected patients. The anastomosis leakage rate ranges between 1-10% depending on the study population (cancer patients vs. non-cancer patients) and the type of anastomosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anastomotic Leak Colon Cancer Right Hemicolectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Monoplus Suture Material

Ileocolic Anastomosis Construction using Monoplus Suture Material after open or laparoscopic surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing a primary, elective either open or laparoscopic right hemicolectomy or right extended hemicolectomy due to malignancy with the creation of an intracorporeal or extracorporeal ileo-colic anastomosis.
* Either complete hand-sewn anastomosis or partial sutured anastomosis (e.g. combination of stapling and suturing)
* Open or laparoscopic as well as conversion from open to laparoscopic surgery
* Absence of peritoneal carcinomatosis
* Absence of vascular, nervous or bone infiltration
* Age ≥ 18 years
* Written data protection declaration (Written Informed consent)

Exclusion Criteria

* Left hemicolectomy or left extended hemicolectomy or sigma resection
* Inflammatory bowel disease (e.g. Crohn´s disease)
* Emergency surgery
* Previous abdominal surgery with bowel resection
* Re-operation of an anastomosis (anastomosis revision surgery)
* Need for stoma creation
* Non-compliant patients
* Participation in an interventional randomized controlled study (RCT)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aesculap AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Markus Golling, Prof. Dr.

Role: STUDY_CHAIR

Diak Klinikum Landkreis Schwäbisch Hall, Dept. of General Surgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Diakonie-Klinikum Landkreis Schwäbisch Hall

Schwäbisch Hall, Baden-Wurttemberg, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Petra Baumann, Dr.

Role: CONTACT

+497461-95 ext. 0

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Markus Golling, Prof. Dr.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAG-O-H-25123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.